Vine Ventures

What is Vine Ventures?

Vine Ventures is a venture capital firm based in San Francisco, CA, United States, specializing in early to mid-stage investments with an emphasis on conscious health and wellbeing. Their investment focus is on psychedelics, covering drug development, manufacturing, distribution, as well as psychedelic culture.

They have a unique approach to health and wellness venture capital, exploring novel approaches and reimagining life sciences. This approach is also reflected in their philanthropic ethos as Vine Ventures donates 50% of their profits back to the mental health community, underlining their commitment to positive impact in the sphere they operate in. Their investment strategy ranges from Seed to Series C, including Pre-IPO stages, with investment sizes between $50,000 and $500,000.

They consider themselves a hands-on, value-add investor with a global perspective, leveraging their experience in early-stage investments to support high-integrity teams and companies that align with their philosophy.

The contents of their website suggest an active engagement with the community through media and conversations with influential figures in the psychedelics and life sciences fields. They share insights into the unique business models evolving within the psychedelic care space and contribute to the ongoing narrative around psychedelics in the media.

Vine Ventures’ team is led by experienced investors such as Ryan Zurrer, who has a significant background in venture investing, biohacking, and was a contributor to the Quantified Self movement. Their approach is mostly characterized by innovativeness, concern for ethical practices within the industry, and a strong interest in contributing to the future of health and wellness. Additionally, Vine Ventures puts a strong emphasis on collaboration and dialogue, as demonstrated by their regular ClubCasts, and they are actively recruiting new talent to join their mission-driven team.

What they say:

We invest in the advancement of conscious health and wellbeing, with a focus on psychedelics (e.g., drug development, manufacturing, distribution) and psychedelic culture.